J&J's Janssen hit with $70 mln verdict in Risperdal trial -lawyers
July 01, 2016 at 15:51 PM EDT
July 1 (Reuters) - A U.S. jury on Friday awarded $70 million to the family of a boy who developed breasts after taking Johnson & Johnson unit Janssen Pharmaceuticals' antipsychotic drug Risperdal, lawyers for the family said.